Information  X 
Enter a valid email address

Gamesys Group PLC (GYS)

  Print      Mail a friend       Annual reports

Monday 02 March, 2020

Gamesys Group PLC

Notice of Results

RNS Number : 7286E
Gamesys Group PLC
02 March 2020
 

 

GAMESYS GROUP PLC

Notice of Results

LONDON (UK) 2 March 2020 - Gamesys Group plc (LSE: GYS) (the "Company"), will announce its financial results for the year ended 31 December 2019 on Tuesday 17 March 2020.

There will be a conference call for analysts and investors at 1.00pm GMT / 9.00am ET on 17 March 2020. To join the call, participants should dial one of the following numbers, using the password 'Gamesys', approximately 10 minutes ahead of the scheduled start time.

UK toll free

0808 109 0700

Canada toll free

1 866 378 3566

USA toll free

1 866 966 5335

Standard international access

+44 (0) 20 3003 2666

A replay facility will be available until and including 17 April 2020 and can be accessed by dialing one of the numbers below and quoting conference ID 6695901#.

Standard international access

+44 (0) 20 8196 1998

USA toll free

1 866 595 5357

 

About Gamesys Group plc

Gamesys Group plc is the parent company of an online gaming group that provides entertainment to a global consumer base. Through its subsidiaries, Gamesys Group plc currently offers bingo and casino games to its customers using brands which include Jackpotjoy (www.jackpotjoy.com), Virgin Games (www.virgingames.com), Botemania (www.botemania.es), Vera&John (www.verajohn.com), Heart Bingo (www.heartbingo.co.uk) and Monopoly Casino (www.monopolycasino.com). For more information about Gamesys Group plc, please visit www.gamesysgroup.com.

Enquiries

Gamesys Group plc

Jason Holden 

Director of Investor Relations 

+44 (0) 207 478 8150 

[email protected] 

 

Finsbury

James Leviton

Andy Parnis

+44 (0) 207 251 3801

[email protected]

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
NORFLFFSVAIFIII

a d v e r t i s e m e n t